Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Mahajan
Shalini
S
Engel
W King
WK
D000047:Academies and Institutes; D000927:Anticonvulsants / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D008274:Magnesium / Q000378:metabolism*; D008275:Magnesium Deficiency / Q000150:complications; D009120:Muscle Cramp / Q000209:etiology / Q000628:therapy*; D012441:Saccharomyces cerevisiae; D013673:Technology Assessment, Biomedical
D000927:Anticonvulsants; D002998:Clonazepam; D008274:Magnesium